Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

FDA product code NQD · 19 cleared devices

Class 2 Immunology
Regulation
21 CFR 866.5270
Review panel
IM
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
2004-01-22 – 2026-04-02

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

↑